Cardiac troponin T and NT-proBNP for detecting myocardial ischemia in suspected chronic coronary syndrome. (15th August 2022)

• Record Type: Journal Article
• Authors: Myhre, Peder L.; Røsjø, Helge; Sarvari, Sebastian I.; Ukkonen, Heikki; Rademakers, Frank; Engvall, Jan E.; Hagve, Tor-Arne; Nagel, Eike; Sicari, Rosa; Zamorano, Jose L.; Monaghan, Mark; D'hooge, Jan; Edvardsen, Thor; Omland, Torbjørn
• Is Part Of: International journal of cardiology. Volume 361(2022)
• Page Start: 14
• Page End: 17
• Publication Date: 2022-08-15
• Subjects: Troponin -- NT-proBNP -- Ischemia -- Myocardial perfusion -- Chronic coronary syndrome -- Biomarker; Cardiology -- Periodicals; Electronic journals; 616.12
• DOI: 10.1016/j.ijcard.2022.05.027
• Languages: English
• ISSNs: 0167-5273

Abstract

Abstract: Background: Elevated N-terminal pro-B-type natriuretic peptides (NT-proBNP) and cardiac troponin T (cTnT) are associated with poor outcome in patients with chronic coronary syndrome (CCS). The performance of these biomarkers in diagnosing ischemia, and their association with myocardial hypoperfusion and hypokinesis is unclear. Methods: Patients with suspected CCS (history of angina, estimated cardiovascular risk >15% or a positive stress test) were included in the prospective, multi-center DOPPLER-CIP study. Patients underwent Single Positron Emission Computed Tomography for assessment of ischemia and NT-proBNP and cTnT were measured in venous blood samples. Results: We included 430 patients (25% female) aged 64 ± 8 years. Reversible hypoperfusion and hypokinesis were present in 139 (32%) and 89 (21%), respectively. Concentrations of NT-proBNP and cTnT correlated moderately (rho = 0.50, p < 0.001). NT-proBNP and cTnT concentrations (median [IQR]) were higher in patients with versus without reversible ischemia: 150 (73–294) versus 87 (44–192) ng/L and 10 (6–13) versus 7 (4–11) ng/L, respectively (p < 0.001 for both), and the associations persisted after adjusting for possible confounders. The C-statistics to discriminate ischemia ranged from 63%–73%, were comparable for cTnT and NT-proBNP, and higher for hypokinesis than hypoperfusion, and both were superior to exercise electrocardiography and stress echocardiography. Very low concentrations (≤5 ng/L cTnT and ≤ 60 ng/L NT-proBNP) ruled out reversible hypokinesis with negative predictive value >90%. Conclusion: cTnT and NT-proBNP are associated with irreversible and reversible ischemia in patients with suspected CCS, particularly hypokinesis. The diagnostic performance was comparable between the biomarkers, and very low concentrations may reliably rule out ischemia. Highlights: Cardiac troponin and NT-proBNP are associated with reversible and irreversible ischemia, even after adjusting for cardiac structure and function. Very low concentrations of both biomarkers may have a value in ruling out ischemia. The association was stronger for hypokinesis than hypoperfusion for both biomarkers, suggesting that the functional effects of ischemia may be a stronger stimulus than ischemia per se. cTnT and NT-proBNP performed better than exercise ECG and stress echocardiography in discriminating for ischemia.